Addressing the burden of steatotic liver disease: The role of transient elastography: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”

書誌詳細
出版年:	Clinical and Molecular Hepatology
主要な著者:	Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed
フォーマット:	論文
言語:	英語
出版事項:	Korean Association for the Study of the Liver 2025-04-01
主題:	masld sld elastography epidemiology
オンライン･アクセス:	http://e-cmh.org/upload/pdf/cmh-2025-0125.pdf

類似資料

The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”
著者:: Donghee Kim, 等
出版事項: (2025-04-01)

Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023
著者:: Donghee Kim, 等
出版事項: (2025-04-01)

Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations
著者:: Pojsakorn Danpanichkul, 等
出版事項: (2025-01-01)

Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality
著者:: Donghee Kim, 等
出版事項: (2024-10-01)

Contemporary burden of mortality from chronic liver disease by sex and race/ethnicity in the United States
著者:: Donghee Kim, 等
出版事項: (2025-07-01)

Prevalence of steatotic liver disease (MASLD, MetALD, ALD) and clinically significant fibrosis in US adolescents
著者:: Guang-Xia Shi, 等
出版事項: (2024-10-01)

Clinical and molecular characterization of steatotic liver disease in the setting of immune-mediated inflammatory diseases
著者:: Enrique García-Nieto, 等
出版事項: (2024-10-01)

From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
著者:: Ming-Lun Yeh, 等
出版事項: (2023-10-01)

Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan
著者:: Chung-Feng Huang, 等
出版事項: (2024-10-01)

The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease
著者:: Zobair M. Younossi, 等
出版事項: (2024-07-01)

Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017–2023
著者:: Donghee Kim, 等
出版事項: (2025-07-01)

Serum uric acid as a biomarker for metabolic dysfunction-associated steatotic liver disease: insights from ultrasound elastography in a Chinese cohort
著者:: Zhe Chang, 等
出版事項: (2025-02-01)

Statin Use in Metabolic Dysfunction-Associated Steatotic Liver Disease and Effects on Vibration-Controlled Transient Elastography-Derived Scores—A Population-Based Inverse Probability Treatment Weighting Analysis
著者:: Natchaya Polpichai, 等
出版事項: (2024-12-01)

Validation of the American Association for the Study of Liver Disease/European Association for the Study of the Liver Multistep Screening Strategies for Metabolic Dysfunction-associated Steatotic Liver disease
著者:: Clémence Marie Canivet, 等
出版事項: (2025-01-01)

The burden of metabolic dysfunction-associated steatotic liver disease and viral hepatitis in Saudi Arabia
著者:: Saleh A. Alqahtani, 等
出版事項: (2024-09-01)

Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
著者:: Katharina Staufer, 等
出版事項: (2023-07-01)

Endothelial dysfunction and cardiovascular risk in non-alcoholic fatty liver disease – a systematic review and meta-analysis
著者:: Nilesh Toke, 等
出版事項: (2024-05-01)

Diagnostic accuracy of two-dimensional shear wave elastography and point shear wave elastography in identifying different stages of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: A meta-analysis
著者:: Xiangyi Xu, 等
出版事項: (2025-01-01)

Microbiota and metabolic dysfunction associated with steatotic liver disease
著者:: Q. Zhu, 等
出版事項: (2024-09-01)

Plasma Circulating Metabolites Associated With Steatotic Liver Disease and Liver Enzymes: A Multiplatform Population-Based Study
著者:: Yasir J. Abozaid, 等
出版事項: (2025-01-01)

Novel eicosanoid signature in plasma provides diagnostic for metabolic dysfunction-associated steatotic liver disease
著者:: Oswald Quehenberger, 等
出版事項: (2024-10-01)

Diagnostic performance of new BAST score versus FIB-4 index in predicating of the liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease
著者:: Eman Helal, 等
出版事項: (2024-09-01)

Reply to correspondence on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”
著者:: Eileen Laurel Yoon, 等
出版事項: (2024-10-01)

Rising drug overdose deaths in chronic liver disease in the United States, 2015–2023
著者:: Donghee Kim, 等
出版事項: (2025-07-01)

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)-related advanced fibrosis and cirrhosis in the United States population utilizing AGILE 3 + and AGILE 4 scores: analysis of the NHANES 2017–2018 cycle
著者:: Naim Alkhouri, 等
出版事項: (2024-07-01)

Steatotic liver disease in chronic hepatitis C related hepatocellular carcinoma: Inflictor or bystander?: Correspondence to editorial on “Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan”
著者:: Chung-Feng Huang, 等
出版事項: (2025-01-01)

Human leukocyte antigen-G in hepatocellular carcinoma driven by chronic viral hepatitis or steatotic liver disease
著者:: Stefano Mocci, 等
出版事項: (2025-04-01)

Correspondence to editorial on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
著者:: Nicholas A. Rouillard, 等
出版事項: (2025-04-01)

Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort
著者:: Antonio Liguori, 等
出版事項: (2025-01-01)

Epidemiology of metabolic dysfunction-associated steatotic liver disease
著者:: Zobair M. Younossi, 等
出版事項: (2025-02-01)

Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD)
著者:: Majid Mufaqam Syed-Abdul
出版事項: (2023-12-01)

A complement to epigenetics in metabolic dysfunction-associated steatotic liver disease: Editorial on “DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease”
著者:: Johanna K. DiStefano, 等
出版事項: (2025-01-01)

Molecular Clustering of Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Transcriptome Analysis
著者:: Gina Ryu, 等
出版事項: (2025-01-01)

Comparing similarities and differences between NAFLD, MAFLD, and MASLD in the general U.S. population
著者:: Haoxuan Zou, 等
出版事項: (2024-07-01)

Resmetirom in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis
著者:: Fares Jamal, 等
出版事項: (2025-08-01)

Applicability of Statins in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
著者:: Thaninee Prasoppokakorn
出版事項: (2025-01-01)

Multidimensional sleep impairment predicts steatotic liver disease spectrum risk
著者:: Dongling Wang, 等
出版事項: (2025-03-01)

Metabolic dysfunction-associated steatotic liver disease across women’s reproductive lifespan and issues
著者:: Clara Meda, 等
出版事項: (2025-01-01)

Correspondence to editorial on “DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease”
著者:: Amal Magdy, 等
出版事項: (2025-01-01)

New steatotic liver disease criteria diagnostic performance in an agricultural population in Chile
著者:: Maria Spencer-Sandino, 等
出版事項: (2025-07-01)